Targeted COPD Screening in Singapore: PUMA Questionnaire and Spirometry Show Cost-Effectiveness
A study in Singapore investigated the cost-effectiveness of a targeted approach to identifying Chronic Obstructive Pulmonary Disease (COPD) cases. The method involved using the PUMA questionnaire as an initial screening tool, followed by spirometry for confirmation among individuals who have ever smoked. This strategy aims to efficiently detect COPD in a high-risk population. The research focused on the economic viability of this two-step diagnostic process. By prioritizing individuals with a history of smoking, the study sought to optimize resource allocation in healthcare. The findings suggest that this targeted case-finding approach is a cost-effective way to manage COPD in Singapore. Early detection through this method can potentially lead to better patient outcomes and reduced long-term healthcare burdens. The study specifically evaluated the costs associated with the questionnaire and spirometry tests against the benefits of early COPD diagnosis.
This study highlights a pragmatic approach to managing COPD, a significant public health challenge, by leveraging cost-effective screening tools. The integration of a questionnaire with a diagnostic test like spirometry represents a rational strategy to identify at-risk individuals efficiently. Such targeted interventions are crucial for optimizing healthcare resource allocation, particularly in aging populations or those with high smoking prevalence. The focus on cost-effectiveness aligns with global trends in healthcare systems seeking sustainable models. Future considerations might include the scalability of this model across different healthcare infrastructures and its long-term impact on patient morbidity and mortality rates, as well as the potential for AI-driven predictive analytics to further refine case-finding strategies.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.